VCP Pharmaceutical Joint Stock Company is a prominent pharmaceutical manufacturer and trader headquartered in Hanoi, Vietnam. Established in 2003 as a joint venture and evolving into a joint stock company in 2008, the organization operates a sophisticated production facility in Soc Son, Hanoi. The company is a leading specialist in the production of powder antibiotics for injection, specifically within the Penicillin and Cephalosporin groups. Its manufacturing capabilities are supported by two dedicated workshops equipped with advanced, automated systems that comply with World Health Organization Good Manufacturing Practice (GMP-WHO) standards. Beyond its core antibiotic lines, the company offers a diverse portfolio including topical medicines (creams, ointments, and gels), herbal medicines, traditional remedies, and functional foods. VCP Pharmaceutical Joint Stock Company serves a broad market by distributing products to hospitals and pharmacies across Vietnam, supported by sales offices in both Hanoi and Ho Chi Minh City. The company also maintains robust international trade operations, engaging in the import of active pharmaceutical ingredients (APIs) and raw materials from global suppliers to support its manufacturing and OEM services. With a workforce of over 100 employees, the company integrates research and development with large-scale production to provide high-quality healthcare solutions including medicinal chemicals, dietary supplements, and specialized pharmaceutical packaging.
Cảm lạnh, đau rát họng, đau nhức mình mẩy
antibiotics, topical medicines, and herbal remedies
VCP Pharmaceutical Joint Stock Company
VCP Pharmaceutical Joint Stock Company Factory
Benadyl
Pharbaco Central Pharmaceutical Joint Stock Company I
Pharbaco Central Pharmaceutical Joint Stock Company I is a premier pharmaceutical manufacturer and distributor based in Hanoi, Vietnam. Established in 1954, the company has a 70-year history as a cornerstone of the national pharmaceutical industry. Operating as a manufacturer, trading company, and OEM/contract manufacturer, Pharbaco maintains a workforce of 501 to 1,000 employees and manages a significant production complex in Soc Son District. The company is recognized for its extensive manufacturing capabilities, featuring modern production lines from Germany, the UK, and the US, and holds certifications including WHO-GMP, EU-GMP, GLP, and GSP.
Pharbaco offers a diverse portfolio of over 500 products across various therapeutic categories, including antibiotics (Cephalosporin, Penicillin, and Carbapenem), cardiovascular medications, anti-inflammatory drugs, vitamins, and dietary supplements. Their production facilities include specialized lines for injectable powders, oral solid dosages (OSD), and traditional medicinal herbs. Beyond pharmaceuticals, the company is involved in the supply of medical equipment, cosmetics, and specialized drugs for national health programs targeting tuberculosis and malaria.
With a strong focus on research and development, Pharbaco operates international-standard laboratories and R&D centers in Hanoi and Ho Chi Minh City. The company has a robust international trade presence, exporting high-quality Vietnamese medicines to over 20 countries and territories worldwide. Listed on the UPCOM market under the ticker PBC, Pharbaco continues to expand its scale through multi-phase factory upgrades to meet evolving global healthcare standards.
Fabafixim
Cefadroxil 250mg
Introduce | Pharbaco
Pharbaco factory
Pharbaco Building
Pharbaco Central Pharmaceutical Joint Stock Company